Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705926 · ClinicalTrials.gov registry record · Phase 1
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00705926: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00705926 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705926, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will determine whether HIV treatment that is initiated during the acute phase of HIV infection, followed by discontinuation of treatment, is effective in reducing the amount of HIV and an increasing the amount of CD4 cells in the blood of people with HIV, compared to the amounts of HIV and CD4 cells in people who do not receive treatment at this stage.
Interventions
- OTHER No treatment
- DRUG Highly Active Antiretroviral Therapy (HAART)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-10 |
| Est. Completion | 2017-07-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705926
The ClinicalTrials.gov registry entry for NCT00705926 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No treatment is the first listed.
NCT00705926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705926 about?
NCT00705926 is a clinical study titled "Effectiveness of Antiretroviral Therapy During Acute HIV Infection". This study will determine whether HIV treatment that is initiated during the acute phase of HIV infection, followed by discontinuation of treatment, is effective in reducing the amount of HIV and an increasing the amount of CD4 cells in the blood of people with HIV, compared to the amounts of HIV an...
What is the current status of trial NCT00705926?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2008-10. Estimated completion is 2017-07-16.
What interventions are being tested in trial NCT00705926?
The interventions under investigation include: No treatment (OTHER), Highly Active Antiretroviral Therapy (HAART) (DRUG).
Who is sponsoring clinical trial NCT00705926?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.